Značaj imunohistohemije i kliničkih podataka u dijagnostici malignih limfoma klasificiranih po R.E.A.L

Authors

  • Nurija Bilalović Medicinski fakultet Univerziteta u Sarajevu, Institut za patologiju
  • Ivan Selak Medicinski fakultet Univerziteta u Sarajevu, Institut za patologiju

DOI:

https://doi.org/10.5644/Radovi.346

Abstract

No abstract available.

References

Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Müller-Hermelink, H. K., Pileri, S. A., Piris, M. A., Ralfkiaer, E., & Warnke, R. A. (1994). A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84(5), 1361–1392.

Pileri, S. A., Milani, M., Fraternali-Orcioni, G., & Sabattini, E. (1998). From the R.E.A.L. classification to the upcoming WHO scheme: A step toward universal categorisation of lymphoma entities? Annals of Oncology, 9, 607–612.

Pittaluga, S., Bijnens, L., Teodorovic, I., Hagenbeek, A., Meerwaldt, J. H., Somers, R., et al. (1996). Clinical analysis of 670 cases in two trials of the EORTC Lymphoma Cooperative Group subtyped according to the REAL classification of lymphoid neoplasms. Blood, 87, 4358–4367.

Melnyk, A., Rodriguez, A., Pugh, W. C., & Cabannillas, F. (1996). Evaluation of the REAL lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin’s lymphoma. Blood.

The Non-Hodgkin’s Lymphoma Classification Project. (1997). A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood, 89, 3909–3918.

The Non-Hodgkin’s Lymphoma Classification Project. (1997). Effect of age on the characteristics and clinical behavior of non-Hodgkin’s lymphoma patients. Annals of Oncology, 8, 973–978.

Jaffe, E. S., Harris, N. L., Diebold, J., & Müller-Hermelink, H. K. (1999). World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report. American Journal of Clinical Pathology, 111(1 Suppl 1), S8–S12.

Jancar, J. (2000). Progress in the classification of myeloid and lymphoid neoplasms: From REAL to WHO concept. Advances in Clinical Pathology, 4, 59–76.

Mason, D., & Gater, K. (1998). Lymphoma classification: The pocket guide. United Kingdom: Marston Book Services.

Knowles, D. M. (Ed.). (1992). Neoplastic hematopathology (pp. 73–167). Baltimore: Williams & Wilkins.

Tubbs, R. R., Fishleder, A., Weiss, R. A., Savage, R. A., Sebek, B. A., & Wick, J. K. (1983). Immunohistologic cellular phenotypes of lymphoproliferative disorders: Comprehensive evaluation of 56 cases including 257 NHL classified by the International Working Formulation. American Journal of Pathology, 113, 207–221.

Warnke, R. A., & Weiss, L. M. (1995). Tumors of lymph nodes and spleen. Washington, DC: Armed Forces Institute of Pathology (AFIP).

Lennert, K., & Feller, A. (1992). Histopathology of non-Hodgkin’s lymphomas (2nd ed.). New York: Springer-Verlag.

Hopwood, A. T. (1957). Proceedings of the Linnean Society of London. Proceedings of the Linnean Society of London, 171, 230–234.

Published

15.06.2002

Issue

Section

Idejni projekti izlagani na plenumu Centra za medicinska istraživanja ANUBiH koji su nakon opsežne diskusije dobili suglasnost za izradu izvedbenih projekata

How to Cite

Značaj imunohistohemije i kliničkih podataka u dijagnostici malignih limfoma klasificiranih po R.E.A.L. (2002). Acta Medica Academica, 31, 211-215. https://doi.org/10.5644/Radovi.346

Most read articles by the same author(s)